ConductScience.org, home

Paper32023707

[Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].

Wu MN and 3 others. Zhonghua Gan Zang Bing Za Zhi, 2020. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. [Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value]. Papers, record 32023707. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32023707

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].
PubMed
Journal
Zhonghua Gan Zang Bing Za Zhi
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Relative citation ratio, by iCite
0.15
iCite
Revised in PubMed
2026-09-19
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wu MNM N
2Sun JYJ Y
3Yao MM
4Yao DFD F

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Carcinoma, HepatocellularMajor topic
ExosomesMajor topic
Liver NeoplasmsMajor topic
MicroRNAsMajor topic
Humans
RNA, Long Noncoding
Tumor Microenvironment

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
81673241, 31872738National Natural Science Foundation of ChinaPubMed
BE2016698The Key Study Project of Jiangsu Province of ChinaPubMed

Source PubMed

Download CSV of grants

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127890434miR-98 inhibits hepatocellular carcinoma cell proliferation via targeting EZH2 and suppressing Wnt/β-catenin signaling pathway.Biomed Pharmacother2017https://conductscience.org/library/papers/27890434PubMed
228781655HCV-E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs.Oncol Lett2017https://conductscience.org/library/papers/28781655PubMed
325686836Hepatocellular carcinoma in a large medical center of China over a 10-year period: evolving therapeutic option and improving survival.Oncotarget2015https://conductscience.org/library/papers/25686836PubMed
428288874Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.Cancer Lett2017https://conductscience.org/library/papers/28288874PubMed
528781949miR-203a-3p.1 targets IL-24 to modulate hepatocellular carcinoma cell growth and metastasis.FEBS Open Bio2017https://conductscience.org/library/papers/28781949PubMed
629510736MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma.J Exp Clin Cancer Res2018https://conductscience.org/library/papers/29510736PubMed
726514126Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.J Hematol Oncol2015https://conductscience.org/library/papers/26514126PubMed
825308172miR-122--a key factor and therapeutic target in liver disease.J Hepatol2015https://conductscience.org/library/papers/25308172PubMed
925503676Vps4A functions as a tumor suppressor by regulating the secretion and uptake of exosomal microRNAs in human hepatoma cells.Hepatology2015https://conductscience.org/library/papers/25503676PubMed
1028098858miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.Int J Oncol2017https://conductscience.org/library/papers/28098858PubMed
1127278244Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: An update for clinicians (Review).Oncol Rep2016https://conductscience.org/library/papers/27278244PubMed
1227463001Exosomes: small vesicles with big roles in hepatocellular carcinoma.Oncotarget2016https://conductscience.org/library/papers/27463001PubMed
1328189396Hepatocellular carcinoma suppressor 1 promoter hypermethylation in serum. A diagnostic and prognostic study in hepatitis B.Clin Res Hepatol Gastroenterol2017https://conductscience.org/library/papers/28189396PubMed
1429313949Cancer statistics, 2018.CA Cancer J Clin2018https://conductscience.org/library/papers/29313949PubMed
1528814883Serum exosomal miR-125b is a novel prognostic marker for hepatocellular carcinoma.Onco Targets Ther2017https://conductscience.org/library/papers/28814883PubMed
1629637568Hepatoma cell-secreted exosomal microRNA-103 increases vascular permeability and promotes metastasis by targeting junction proteins.Hepatology2018https://conductscience.org/library/papers/29637568PubMed
1727878280Loss of miR-638 promotes invasion and epithelial-mesenchymal transition by targeting SOX2 in hepatocellular carcinoma.Oncol Rep2017https://conductscience.org/library/papers/27878280PubMed
1828750499Exosomal miR-9-3p suppresses HBGF-5 expression and is a functional biomarker in hepatocellular carcinoma.Minerva Med2018https://conductscience.org/library/papers/28750499PubMed
1930148162Exosomes in the Oncobiology, Diagnosis, and Therapy of Hepatic Carcinoma: A New Player of an Old Game.Biomed Res Int2018https://conductscience.org/library/papers/30148162PubMed
2029858059Hepatocellular Carcinoma Cell-Secreted Exosomal MicroRNA-210 Promotes Angiogenesis In Vitro and In Vivo.Mol Ther Nucleic Acids2018https://conductscience.org/library/papers/29858059PubMed

See all 40 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
40620503Non-coding RNAs in alcohol-associated liver disease.Liver Res2025https://conductscience.org/library/papers/40620503PubMed
38238951[miR-200a involvement in the biological behavior of hepatoma carcinoma cells by targeting the regulatory expression of mesenchymal-epithelial transition factor].Zhonghua Gan Zang Bing Za Zhi2023https://conductscience.org/library/papers/38238951PubMed
36891706[Research progress and clinical application value of exosomal circRNAs in hepatocellular carcinoma].Zhonghua Gan Zang Bing Za Zhi2022https://conductscience.org/library/papers/36891706PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32023707

GET https://conductscience.org/api/papers/v1/32023707/references?page=2